Aemetis, Inc. (NASDAQ:AMTX) Sees Large Increase in Short Interest

Aemetis, Inc. (NASDAQ:AMTX - Get Free Report) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 5,710,000 shares, an increase of 5.4% from the May 31st total of 5,420,000 shares. Based on an average daily volume of 697,900 shares, the days-to-cover ratio is presently 8.2 days.

Aemetis Stock Performance

Aemetis stock traded up $0.17 during mid-day trading on Wednesday, hitting $3.14. The company's stock had a trading volume of 642,141 shares, compared to its average volume of 947,706. The company has a 50 day moving average of $3.50 and a 200-day moving average of $3.92. The stock has a market cap of $139.42 million, a PE ratio of -2.68 and a beta of 1.32. Aemetis has a one year low of $2.75 and a one year high of $8.99.

Aemetis (NASDAQ:AMTX - Get Free Report) last issued its earnings results on Thursday, May 9th. The specialty chemicals company reported ($0.58) earnings per share for the quarter, missing the consensus estimate of ($0.43) by ($0.15). The business had revenue of $72.63 million during the quarter, compared to analyst estimates of $78.74 million. On average, equities research analysts forecast that Aemetis will post -1.59 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

AMTX has been the topic of several analyst reports. StockNews.com raised Aemetis to a "sell" rating in a research report on Monday, June 3rd. HC Wainwright reaffirmed a "buy" rating and issued a $28.00 price objective on shares of Aemetis in a research report on Friday, May 10th. Finally, Truist Financial reaffirmed a "hold" rating and issued a $4.00 price objective (up previously from $3.50) on shares of Aemetis in a research report on Monday, May 13th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $12.25.

Insider Activity

In other news, Director John R. Block sold 51,580 shares of the business's stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of $3.49, for a total transaction of $180,014.20. Following the transaction, the director now owns 14,001 shares of the company's stock, valued at approximately $48,863.49. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 16.44% of the company's stock.

Institutional Investors Weigh In On Aemetis

Several hedge funds have recently made changes to their positions in AMTX. SG Americas Securities LLC purchased a new stake in shares of Aemetis during the 1st quarter worth $60,000. State Board of Administration of Florida Retirement System purchased a new stake in Aemetis in the first quarter valued at about $84,000. Citigroup Inc. raised its stake in Aemetis by 10,391.3% in the third quarter. Citigroup Inc. now owns 75,013 shares of the specialty chemicals company's stock valued at $311,000 after buying an additional 74,298 shares during the last quarter. Finally, Stifel Financial Corp raised its stake in Aemetis by 58.0% in the third quarter. Stifel Financial Corp now owns 691,445 shares of the specialty chemicals company's stock valued at $2,870,000 after buying an additional 253,745 shares during the last quarter. 27.02% of the stock is currently owned by hedge funds and other institutional investors.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.